Defining And Implementing The Right Oncology Digital Strategy

Oncology clinical trials face significant challenges in enrollment, efficiency, and patient access. However, promising solutions are being explored through recent advancements in digital health technologies (DHTs), decentralized trial methods, and regulatory support. The FDA’s guidance on Direct-to-Patient (DTP) approaches, electronic Patient-Reported Outcomes (ePROs), and DHTs is fostering patient-centric trials and encouraging digital integration. DHT adoption in clinical research has surged, growing 97% in the last five years, with a notable increase in digital endpoints, doubling every three years since 2015.

Key topics of this webinar include defining digital strategies, the role of digital biomarkers in expediting development, and the impact of Medable’s novel technologies on trial timelines. These insights underscore the transformative potential of digital health in overcoming oncology trial challenges, improving patient engagement, and accelerating therapeutic advancements.